Status | Study |
Completed |
Study Name: Study Evaluating Impact of IL-7 on CD4 Lymphopenia, Risks of Severe Haematological Toxicity and Tumor Progression in Metastatic Breast Cancer Patients Condition: Metastatic Breast Cancer Date: 2011-06-06 Interventions: Drug: placebo Placebo before t |
Completed |
Study Name: Prognostic Value of Divpenia and CD4 Count in Relapsed Breast or Lung Cancer Patients Condition: Breast Cancer Lung Cancer Date: 2011-02-28 Interventions: Biological: Breast cancer cohort |
Completed |
Study Name: Risk Factors for Low Lymphocyte Count in Patients With Type 2 Diabetes Condition: Diabetes Mellitus, Type 2 Date: 2010-08-30 |
Recruiting |
Study Name: Etiology, Pathogenesis, and Natural History of Idiopathic CD4+ Lymphocytopenia Condition: Idiopathic CD4+ Lymphocytopenia Cryptococcal Meningitis Date: 2009-03-20 |
Completed |
Study Name: Newborn Screening for Severe Combined Immunodeficiency (SCID) in a High-Risk Population Condition: Severe Combined Immunodeficiency T Cell Lymphocytopenia Date: 2009-02-17 |
Terminated |
Study Name: Interleukin-7 (CYT107) Treatment of Idiopathic CD4 Lymphocytopenia: Expansion of CD4 T Cells (ICICLE) Condition: Idiopathic CD4+ T-Lymphocytopenia Date: 2009-02-06 Interventions: Drug: CYT107 |
Terminated |
Study Name: Study of Drug to Reduce Thrombocytopenia in Patients Receiving Chemo for Ovarian, Fallopian Tube or Peritoneal Cancer Condition: Thrombocytopenia Neutropenia Lymphop Date: 2008-10-09 Interventions: Drug: TXA127 Once daily subcut |
Completed |
Study Name: Evaluation of Recovery From Drug-Induced Lymphopenia Using Cytomegalovirus-specific T-cell Adoptive Transfer Condition: Glioblastoma Date: 2008-06-03 Interventions: Biological: CMV-ALT + CMV-DCs |
Active, not recruiting |
Study Name: Vaccine Therapy in Treating Patients With Newly Diagnosed Glioblastoma Multiforme Condition: Malignant Neoplasms of Brain Date: 2008-03-19 Interventions: Biological: tetanus toxoid Giv |
Active, not recruiting |
Study Name: Basiliximab in Treating Patients With Newly Diagnosed Glioblastoma Multiforme Undergoing Targeted Immunotherapy and Temozolomide-Caused Lymphopenia Condition: Malignant Neoplasms Brain Date: 2008-02-28 Interventions: Biological: RNA-loaded dendritic cell vaccine |